Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ASH1L | Q9NR48 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9272489 | 0.85 | ABL1 (0.43) | ASH1L | |
| SCHEMBL9273497 | 0.82 | ASH1L (0.44) | ASH1L | |
| SCHEMBL9265705 | 0.82 | PLD2 (0.41) | ASH1LCHRM3 | |
| SCHEMBL9272525 | 0.81 | ASH1L (0.41) | ASH1LCHRM3 | |
| SCHEMBL9270580 | 0.80 | SLC2A1 (0.43) | ASH1L | |
| SCHEMBL9287294 | 0.80 | PRKCG (0.42) | ASH1L | |
| SCHEMBL9287300 | 0.78 | DRD2 (0.47) | ASH1L | |
| SCHEMBL9273642 | 0.78 | KDM1A (0.41) | ASH1LKDM1A | |
| SCHEMBL9269584 | 0.78 | CARM1 (0.43) | ASH1L | |
| SCHEMBL9268846 | 0.77 | ASH1L (0.42) | ASH1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5393761-A | Treatment of nervous system disorders | H. LUNDBECK A/S (DK) | 1995-02-28 | — | — | US | disclosed |
| EP-0470039-B1 | Novel 3-arylindole and 3-arylindazole derivatives | LUNDBECK & CO AS H (DK) | 1994-12-07 | — | — | EP | disclosed |
| EP-0470039-A2 | Novel 3-arylindole and 3-arylindazole derivatives | H. LUNDBECK A/S (DK) | 1992-02-05 | — | — | EP | disclosed |